Results 81 to 90 of about 732,366 (171)

Transcatheter Tricuspid Valve Clinical Trials: Incomplete Data and FDA-Approved Devices

Structural Heart
Each reviewed trial of transcatheter tricuspid valve intervention demonstrated clinically meaningful improvement in Kansas City Cardiomyopathy Questionnaire (KCCQ)-defined quality of life and favorable right ventricular remodeling.
Deborah Furman, MD, Brian Whisenant, MD
doaj   +1 more source

Transcatheter tricuspid valve replacement

, 2012
Despite the explosion in the field of transcatheter aortic valve implantations over the last 10 years, only a handful of transcatheter tricuspid valve-in-valve implants have been described to date. This review describes the basic anatomy and pathology of
Weich H.
core  

Cardiac Implantable Electronic Devices and Transcatheter Tricuspid Valve Replacement With the EVOQUE System: A Case-Review Series Highlighting Procedural and Management Considerations

Structural Heart
Severe, untreated tricuspid regurgitation is associated with worse clinical outcomes. While isolated tricuspid valve (TV) surgery has been linked to poor long-term outcomes, transcatheter TV therapies, including edge-to-edge repair and transcatheter ...
Raviteja R. Guddeti, MD, Puvi Seshiah, MD, Richard Bae, MD, Nadia El-Hangouche, MD, Alex Costea, MD, Edward Schloss, MD, Mehmet Yildiz, MD, Santiago Garcia, MD   +7 more
doaj   +1 more source

Inequities in Access to Tricuspid Valve Treatments

JACC: Advances
Background: Opportunities to minimize inequities in accessing treatments for tricuspid regurgitation disease should be considered. Objective: The objective of this study was to explore how access to new tricuspid regurgitation technologies change when ...
Colin M. Barker, MD, Lisa S. Kemp, PhD, Melissa Mancilla, MBA, Sarah Mollenkopf, MPH, Candace Gunnarsson, PhD, Michael Ryan, MS, Guy David, PhD   +6 more
doaj   +1 more source

Post-stenotic aortic dilatation. [PDF]

, 2006
Aortic stenosis is the most common valvular heart disease affecting up to 4% of the elderly population. It can be associated with dilatation of the ascending aorta and subsequent dissection.
Jahangiri Marjan, Marjan Jahangiri, Wilton, E, Emma Wilton, Jahangiri, M, Wilton Emma   +5 more
core   +2 more sources

Emerging Utilization of Transcatheter Tricuspid Valve Replacement in Severe Tricuspid Regurgitation

, 2023
Emerging Utilization of Transcatheter Tricuspid Valve Replacement in Severe Tricuspid Regurgitation, Dr. Anas Hashem, RGH IMRP and Dr. Jeremiah Depta, Cardiology Department Objectives: Anatomy and physiology of Tricuspid Valve (TV) Pathophysiology ...
Hashem, Anas, Depta, Jeremiah P
core  

Imaging techniques in transcatheter aortic valve replacement

, 2013
Robert A Quaife, Jennifer Dorosz, John C Messenger, Ernesto E Salcedo Division of Cardiology, University of Colorado, Aurora, CO, USA Abstract: Calcific aortic stenosis is now understood as a complex valvular degenerative process sharing many risk ...
Quaife RA, Salcedo EE, Dorosz J, Messenger JC   +3 more
core  

Transjugular tricuspid valve‐in‐ring replacement using the novel system under three‐dimensional printing guidance

ESC Heart Failure
Recurrent tricuspid regurgitation after failed ring annuloplasty is associated with high mortality rates and unfavourable clinical outcomes. Transcatheter tricuspid valve‐in‐ring (TVIR) replacement offers an alternative to high‐risk surgical reoperation,
Yiwei Wang, Yang Liu, Jian Yang
doaj   +1 more source

Anaesthesia for transvenous transcatheter tricuspid valve-in-valve implantation [PDF]

, 2011
The authors report and discuss the anaesthetic management of a transvenous transcatheter tricuspid valve replacement. The conduct of anaesthesia, the challenges encountered and the specific risks associated with the procedure will be discussed ...
Coetzee, AR, Le Roux, P, Du Preez, LJ
core  

Patient Selection for Transcatheter Tricuspid Valve Intervention: Not Too Early, Not Too Late

Structural Heart
Tricuspid regurgitation (TR) is a common but frequently underrecognized condition associated with substantial morbidity and mortality. Long regarded as a mere bystander of left-sided heart disease, TR was often left untreated, contributing to late ...
Jennifer von Stein, MD, Philipp von Stein, MD, Maria C. Alu, MS, Andrea Scotti, MD, Edwin C. Ho, MD, Juan F. Granada, MD, Azeem Latib, MD   +6 more
doaj   +1 more source